Stay updated on Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page.

Latest updates to the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedUpdate: page now includes a government-operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference2%
- Check19 days agoChange DetectedUpdate includes a new version tag (v3.1.0) and removal of several risk-related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision tag (v3.0.2).SummaryDifference0.2%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has updated its facility and location information, now listing 97 locations across various countries, including South Korea, Russia, Germany, Hungary, Poland, Spain, and Taiwan. Additionally, new studies related to the drug guselkumab have been added, enhancing the content on drug safety and efficacy.SummaryDifference12%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page.